MAP2K1 and exocrine pancreatic carcinoma: When similar analyses were performed with breast, colonic, and pancreatic carcinoma lineages, the SRPK1 knockdown impacted the expression of MAP2K2 instead of MAP2K1 [19], providing additional evidence for this different response according to each cell line.